Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy.
about
A Double-Switch Cell Fusion-Inducible Transgene Expression System for Neural Stem Cell-Based Antiglioma Gene Therapy.VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy.
P2860
Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Fusogenic activity of vesicula ...... nhancer of IL-12 gene therapy.
@ast
Fusogenic activity of vesicula ...... nhancer of IL-12 gene therapy.
@en
type
label
Fusogenic activity of vesicula ...... nhancer of IL-12 gene therapy.
@ast
Fusogenic activity of vesicula ...... nhancer of IL-12 gene therapy.
@en
prefLabel
Fusogenic activity of vesicula ...... nhancer of IL-12 gene therapy.
@ast
Fusogenic activity of vesicula ...... nhancer of IL-12 gene therapy.
@en
P2093
P356
P1433
P1476
Fusogenic activity of vesicula ...... nhancer of IL-12 gene therapy.
@en
P2093
P2888
P356
10.1038/SJ.CGT.7700270
P577
2001-01-01T00:00:00Z
P5875
P6179
1009160634